
Sunday, December 11, 2022 1:03:35 AM
i hope NOT
My exremely humble opinion.
In short i would say GMDAs science is good,
management is by far less.

Liked By
Spread the love. Be the first to like this post!
Recent GMDA News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/27/2023 11:16:25 AM
- Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update • Business Wire • 03/27/2023 11:00:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/22/2023 08:35:41 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/20/2023 08:46:51 PM
- Gamida Cell Announces Changes to Board of Directors • Business Wire • 03/20/2023 08:30:00 PM
- Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast • Business Wire • 03/20/2023 12:00:00 PM
- Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference • Business Wire • 03/07/2023 01:00:00 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 03/03/2023 09:03:47 PM
- Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR • Business Wire • 02/18/2023 05:30:00 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/14/2023 09:10:55 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:02:40 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/30/2023 12:03:54 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/30/2023 12:01:20 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 01/23/2023 11:04:06 AM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 01/20/2023 09:32:22 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/19/2023 09:44:26 PM
- Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 01/10/2023 10:13:59 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 05:16:06 PM
- Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) • Edgar (US Regulatory) • 12/30/2022 10:17:38 PM
- Analysts’ Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Arcutis Biotherapeutics (ARQT) • TipRanks • 12/12/2022 06:11:45 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 12:16:53 PM
- Gamida Cell Announces Closing of $25 Million Financing With Highbridge • Business Wire • 12/12/2022 12:00:00 PM
- Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences • Business Wire • 11/23/2022 01:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/22/2022 09:37:38 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/22/2022 09:35:07 PM
FEATURED Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • Mar 30, 2023 10:00 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM
ReoStar Energy Corporation Acquires Interest in Emerging Global Iron Ore Producer Leuffer Mining Group • REOS • Mar 30, 2023 9:05 AM
Chilco River Holdings Announces Acquisition of L. Myers Associates • CRVH • Mar 30, 2023 9:00 AM
Alliance Creative Group (ACGX) Reports Revenue of $3,399,008 for Fourth Quarter of 2022 • ACGX • Mar 30, 2023 8:30 AM